Formycon’s Acquisition of the Biosimilar Candidates FYB201 and FYB202

Laura Testa
Tagged:

DLA Piper has advised Active Ownership Capital as anchor shareholder of Formycon on the deal. honert, Norton Rose Fulbright, Baumann Inderkum & Muheim and Ashurst advised…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now